Species differences in [11C]clorgyline binding in brain. Other Scholarly Work

Fowler, JS, Ding, YS, Logan, J et al. (2001). Species differences in [11C]clorgyline binding in brain. . 28(7), 779-785. 10.1016/s0969-8051(01)00245-1

cited authors

  • Fowler, JS; Ding, YS; Logan, J; MacGregor, RR; Shea, C; Garza, V; Gimi, R; Volkow, ND; Wang, GJ; Schlyer, D; Ferrieri, R; Gatley, SJ; Alexoff, D; Carter, P; King, P; Pappas, N; Arnett, CD

authors

abstract

  • [11C]Clorgyline selectively binds to MAO A in the human brain. This contrasts with a recent report that [11C]clorgyline (in contrast to other labeled MAO A inhibitors) is not retained in the rhesus monkey brain [4]. To explore this difference, we compared [11C]clorgyline in the baboon brain before and after clorgyline pretreatment and we also synthesized deuterium substituted [11C]clorgyline (and its nor-precursor) for comparison. [11C]Clorgyline was not retained in the baboon brain nor was it influenced by clorgyline pretreatment or by deuterium substitution, contrasting to results in humans. This suggests a species difference in the susceptibility of MAO A to inhibition by clorgyline and represents an unusual example of where the behavior of a radiotracer in the baboon brain does not predict its behavior in the human brain.

publication date

  • October 1, 2001

keywords

  • Animals
  • Brain
  • Carbon Radioisotopes
  • Clorgyline
  • Deuterium
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Indicators and Reagents
  • Isotope Labeling
  • Monoamine Oxidase
  • Monoamine Oxidase Inhibitors
  • Papio
  • Radiopharmaceuticals
  • Species Specificity
  • Tomography, Emission-Computed

Digital Object Identifier (DOI)

Medium

  • Print

start page

  • 779

end page

  • 785

volume

  • 28

issue

  • 7